Furthermore, certain factors are associated with reduced response to resection with adjuvant chemoradiation, such as IDH-wildtype GBM without methylguanine methyltransferase (MGMT) promoter methylation, poor tumor excisability, and resistance to chemotherapy [13,14]. Here, MGMT is linked to glioblastoma.